EUVIMEDEUVIMED entdecken
Leserbrief

Combination therapy of ustekinumab and immunomodulator for inflammatory bowel disease: concerns about the different results observed between two meta‐analyses

T Yoshihara iD, S Shinzaki iD, H Iijima, Y Tsujii, Y Hayashi iD, T Takehara iD

Journal of Gastroenterology and Hepatology · 2023

DOI: 10.1111/jgh.16161 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Gastroenterology and Hepatology, 2023. Verfasst von T Yoshihara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan. Hauptthemen laut MEDLINE: Ustekinumab, Inflammatory Bowel Diseases. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Data S1. Supporting Information. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UstekinumabInflammatory Bowel DiseasesHumansImmunologic FactorsCombined Modality TherapyTreatment Outcome

Substanzen

UstekinumabImmunologic Factors

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo Medical University, Nishinomiya, Japan.

ORCID-Profile: T Yoshihara, S Shinzaki, Y Hayashi, T Takehara

Zitieren

APA

Yoshihara, T., Shinzaki, S., Iijima, H., Tsujii, Y., Hayashi, Y., & Takehara, T. (2023). Combination therapy of ustekinumab and immunomodulator for inflammatory bowel disease: concerns about the different results observed between two meta‐analyses. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16161

Vancouver

Yoshihara T, Shinzaki S, Iijima H, Tsujii Y, Hayashi Y, Takehara T. Combination therapy of ustekinumab and immunomodulator for inflammatory bowel disease: concerns about the different results observed between two meta‐analyses. Journal of Gastroenterology and Hepatology. 2023. doi:10.1111/jgh.16161

BibTeX
@article{Yoshihara2023,
  author = {Yoshihara, T and Shinzaki, S and Iijima, H and Tsujii, Y and Hayashi, Y and Takehara, T},
  title = {Combination therapy of ustekinumab and immunomodulator for inflammatory bowel disease: concerns about the different results observed between two meta‐analyses},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2023},
  doi = {10.1111/jgh.16161}
}
Kostenlos starten →